scL-2PAM: A Novel Countermeasure That Ameliorates Neuroinflammation and Neuronal Losses in Mice Exposed to an Anticholinesterase Organophosphate. [PDF]
Moghe M +6 more
europepmc +1 more source
Harnessing ferroptosis from multilayer defense networks to nanoplatforms for specific cancer therapy
Nanomaterials target metabolically‐regulated ferroptosis for cancer therapy. Iron‐based or alternative nanoplatforms integrate ferroptosis with chemotherapy, immunotherapy, or radiotherapy. They enable stimulus‐responsive therapies (photothermal, photodynamic, sonodynamic) activated by near‐infrared, light, or ultrasound, achieving potent synergistic ...
Xinyue Xu +5 more
wiley +1 more source
Ferroptosis in AML: nanoparticles, biomarkers, and immune rewiring for therapeutic breakthroughs. [PDF]
Tavakoli F +8 more
europepmc +1 more source
Targeting p53 in anticancer therapy: Searching for new small molecule activators. [PDF]
Beatriz Sampaio da Silva
core
Schematic illustration of preparation of injectable H/G@Co@miR‐206 hydrogel for efficient skeletal muscle regeneration in cardiotoxin‐induced skeletal muscle injury SD rat model. Abstract The effective treatment of acute skeletal muscle injuries remains challenging, necessitating therapeutic strategies that concurrently reestablish vascular perfusion ...
Zhengzhe Han +9 more
wiley +1 more source
A Pralidoxime Nanocomplex Formulation Targeting Transferrin Receptors for Reactivation of Brain Acetylcholinesterase After Exposure of Mice to an Anticholinesterase Organophosphate. [PDF]
Pirollo KF +7 more
europepmc +1 more source
This study provides an integrated spherical nucleic acid nanoreactor (denoted as AMCuD) for targeted PD‐L1 degradation and chemo‐dynamically enhanced cuproptosis to synergically elicit robust immunotherapy against the triple‐negative breast cancer (TNBC) growth, recurrence and metastasis.
Ningxi Li +9 more
wiley +1 more source
Advancements in bioscavenger mediated detoxification of organophosphorus poisoning. [PDF]
Li H +9 more
europepmc +1 more source
Screening of efficient salicylaldoxime reactivators for DFP and paraoxon-inhibited acetylcholinesterase. [PDF]
Wei Z +6 more
europepmc +1 more source
Molecular targets and therapies associated with poor prognosis of triple‑negative breast cancer (Review). [PDF]
Kim ES.
europepmc +1 more source

